HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines-Executive summary.

AuthorsJoanna Tieu, Rona Smith, Neil Basu, Paul Brogan, David D'Cruz, Neeraj Dhaun, Oliver Flossmann, Lorraine Harper, Rachel B Jones, Peter C Lanyon, Raashid A Luqmani, Stephen P McAdoo, Chetan Mukhtyar, Fiona A Pearce, Charles D Pusey, Joanna C Robson, Alan D Salama, Lucy Smyth, Richard A Watts, Lisa C Willcocks, David R W Jayne
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 59 Issue 4 Pg. 727-731 (04 01 2020) ISSN: 1462-0332 [Electronic] England
PMID32096542 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antirheumatic Agents
  • Rituximab
Topics
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (drug therapy)
  • Antirheumatic Agents (therapeutic use)
  • Consensus Development Conferences as Topic
  • Delphi Technique
  • Humans
  • Maintenance Chemotherapy
  • Rituximab (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: